We are live on ! Find out more
OP

Omni Partners Portfolio holdings

AUM $2.03B
1-Year Est. Return 126.33%
This Fund
S&P 500
This Quarter Est. Return
+7.3%
1 Year Est. Return
+126.33%
3 Year Est. Return
+411.65%
5 Year Est. Return
+1,549.93%
10 Year Est. Return
AUM
$580M
AUM Growth
-$204M
Cap. Flow
-$218M
Cap. Flow %
-37.61%
Top 10 Hldgs %
94.76%
Holding
43
New
19
Increased
4
Reduced
1
Closed
19

Sector Composition

1 Technology 66.02%
2 Utilities 16.91%
3 Healthcare 5.88%
4 Financials 2.28%
5 Communication Services 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QDEL icon
26
QuidelOrtho
QDEL
$1.24B
-146,189
Closed -$6.41M
PRTK
27
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-147,700
Closed -$3.71M
DISCK
28
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
-175,586
Closed -$3.56M
P
29
DELISTED
Pandora Media Inc
P
-26,001
Closed -$200K
TWX
30
DELISTED
Time Warner Inc
TWX
-903,465
Closed -$92.6M
SNI
31
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
-134,044
Closed -$11.5M
FIG
32
DELISTED
Fortress Investment Group Llc
FIG
-3,863,657
Closed -$31M
ABCO
33
DELISTED
Advisory Board Co
ABCO
-510,735
Closed -$27.4M
BRCD
34
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
-668,211
Closed -$7.99M
RICE
35
DELISTED
Rice Energy Inc.
RICE
-2,876,151
Closed -$83.2M
LVLT
36
DELISTED
Level 3 Communications Inc
LVLT
-951,789
Closed -$50.7M
KITE
37
DELISTED
Kite Pharma, Inc.
KITE
-661,711
Closed -$119M
ALR
38
DELISTED
Alere Inc
ALR
-711,971
Closed -$36.3M
PRXL
39
DELISTED
Parexel International Corp
PRXL
-472,903
Closed -$41.7M
BCR
40
DELISTED
CR Bard Inc.
BCR
-108,130
Closed -$34.7M
NDRM
41
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
-1,116,596
Closed -$43.4M
DDC
42
DELISTED
Dominion Diamond Corporation
DDC
-306,879
Closed -$4.35M
FGL
43
DELISTED
Fidelity & Guaranty Life
FGL
-470,939
Closed -$14.6M

Similar funds

Omni Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Omni Partners held 43 positions worth $580M, down 26% from $783M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Omni Partners withdrew a net $218M in Q4 2017, closing 19 positions and reducing 1 holding. Its most notable exit was Kite Pharma, Inc., an estimated $119M position sold in full.

By sector, the portfolio is most concentrated in Technology at 66% of assets, up from 11% a quarter earlier, followed by Utilities and Healthcare.

Against the trend, Omni Partners opened a new position in Cavium, Inc. worth $30.1M.

  • Omni Partners's largest Q4 2017 buy was Cavium, Inc.: 359,037 shares worth $30.1M.
  • Omni Partners added most to NXP Semiconductors in Q4 2017, an estimated $254M increase.
  • Omni Partners's biggest Q4 2017 reduction was Akorn Inc, cutting an estimated $1.43M.
  • Omni Partners fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $119M.
  • Omni Partners's ten largest holdings make up 95% of its $580M portfolio in Q4 2017.
  • Omni Partners opened 19 new positions and closed 19 in Q4 2017.
  • Omni Partners's portfolio value fell 26% quarter-over-quarter to $580M.

Based on Omni Partners's 13F filing for Q4 2017, filed 22 Jan 2018.